Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133971) titled 'synthetic MR from simulation CT for target delineation in radiotherapy of brain metastases' on Oct. 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Beijing Shijitan Hospital , Capital Medical University
Condition:
brain metastases
Intervention:
Synthetic MRI group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: Synthetic MRI group:100;Diagnostic MRI group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=328399
Disclaimer: Curated by HT Syndication....